Bluestar Adisseo Company
600299
Classement en actions
#4273
Bluestar Adisseo Company operates as a global leader in the development,... Bluestar Adisseo Company operates as a global leader in the development, production, and distribution of specialized feed additives for animal nutrition. The company's diverse product portfolio includes Rhodimet, a range of methionine-based solutions for monogastric animals, offered in both solid (Rhodimet NP99) and liquid (Rhodimet AT88) forms. Additionally, it provides advanced nutritional formulas, such as Smartamine and MetaSmart, which are engineered to ensure optimal amino acid balance in the diets of lactating dairy cows and other ruminants. Its Microvit range offers a comprehensive selection of vitamins essential for the feed industry. Adisseo also produces a diverse array of enzyme preparations under the Rovabio brand, formulated to enhance the digestibility of plant-based raw materials for various animal species, including poultry and swine. Another significant offering is Selisseo 2% Se, an organic selenium source based on seleno-hydroxy-methionine, designed for integration into animal feed. The firm supplies AdiSodium, a chloride-free sodium alternative that supports dietary electrolyte balance in monogastric feeds and delivers an assimilable form of sulfur to ruminant diets. Furthermore, Alterion is provided to improve animal gut health and overall performance by fostering a balanced intestinal micro-ecosystem. Complementing its product portfolio, the company provides several specialized services. PNE utilizes Near-Infrared (NIR) technology to accurately predict the nutritional quality of feed raw materials. DiM offers dedicated assistance and application support for its Rhodimet AT88 product. Lastly, E-lab is an online portal facilitating analytical requests and simplifying sample identification for customers prior to shipment to Adisseo's laboratories. Founded in 1939 and headquartered in Beijing, China, Bluestar Adisseo Company functions as a subsidiary of China National Bluestar (Group) Co., Ltd.
Prix de l'action
$1.18
Capitalisation boursière
$3.64B
Changement (1 jour)
-2.35%
Changement (1 an)
-10.43%
Pays
CN
Échange Bluestar Adisseo Company (600299)
Catégorie
Basic Materials
Ratio P/E pour Bluestar Adisseo Company (600299)
Ratio P/E au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Bluestar Adisseo Company, le ratio P/E actuel (TTM) est de 0. À la fin de l’année 2026, le P/E de l’entreprise était de 0.
Historique du ratio P/E pour Bluestar Adisseo Company de 2001 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2025 | 20.86 | -25.36% |
| 2024 | 27.95 | -93.01% |
| 2023 | 400.00 | 2,151.09% |
| 2022 | 17.77 | -20.86% |
| 2021 | 22.45 | -1.69% |
| 2020 | 22.84 | -23.59% |
| 2019 | 29.89 | -6.84% |
| 2018 | 32.09 | 56.60% |
| 2017 | 20.49 | -0.26% |
| 2016 | 20.54 | -36.35% |
| 2015 | 32.28 | 99.94% |
| 2014 | 16.14 | 594.56% |
| 2013 | 2.32 | -177.60% |
| 2012 | -3.00 | -105.68% |
| 2011 | 52.71 | -43.58% |
| 2010 | 93.43 | -313.28% |
| 2009 | -43.81 | 75.08% |
| 2008 | -25.02 | -169.55% |
| 2007 | 35.97 | 12.18% |
| 2006 | 32.07 | 120.70% |
| 2005 | 14.53 | -29.26% |
| 2004 | 20.54 | -29.30% |
| 2003 | 29.05 | -38.09% |
| 2002 | 46.93 | -33.66% |
| 2001 | 70.74 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 31.66 | - |
GB
|
|
| - | - |
FR
|
|
| 29.64 | - |
US
|
|
| 38.37 | - |
US
|
|
| -1.41K | - |
US
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.